CHO cells |
βig-H3 inhibits cell attachment in vitro and suppresses the growth of CHO tumor cells in nude mice |
[48] |
RGD peptides released from βig-H3 mediate apoptosis of CHO tumor cells |
[49] |
HeLa cells |
RGD peptides released from βig-H3 mediate apoptosis of HeLa tumor cells |
[49] |
Bronchial epithelial cells |
βig-H3 overexpression suppresses tumorigenicity in radiation-induced tumorigenic human bronchial epithelial cells |
[50] |
Loss of βig-H3 expression is associated with the tumorigenic phenotype in asbestos-treated bronchial epithelial cells |
[51] |
βig-H3 gene down-regulation is involved in heavy-ion radiation-induced tumorigenesis of human bronchial epithelial cells |
[52] |
Lung adenocarcinoma |
Loss of βig-H3 protein is frequent in primary lung carcinoma and related to tumorigenic phenotype in lung cancer cells |
[53] |
Promoter methylation contributes to promoter silencing of the βig-H3 gene in human lung cancer cells |
[47] |
βig-H3 is down-regulated in radiation-induced thymic lymphoma model in BALB/c mice |
[5] |
βig-H3 overexpression in H522 lung carcinoma cells reduces motility in vitro and metastasis in vivo
|
[54] |
RGD βig-H3 peptides mediate apoptosis of H1299 lung carcinoma cells |
[49] |
Mesothelioma cell lines |
βig-H3 knockdown increases proliferation and anchorage independent growth of mesothelioma cell lines |
[55] |
Breast carcinoma |
βig-H3 protein expression is reduced in in situ ductal carcinoma and breast carcinoma tissues, compared to benign tissues |
[54] |
βig-H3 overexpression in MCF-7 cells reduces motility in vitro and metastasis in vivo
|
[54] |
Neuroblastoma |
βig-H3 significantly reduces proliferation and invasion of neuroblastoma cell in vitro and in vivo
|
[2,56] |
Osteosarcoma |
C-terminal fragment of βig-H3 is required for apoptosis in human osteosarcoma cells |
[57] |
Hepatoma |
RGD βig-H3 peptides mediate apoptosis of Hep3B hepatoma cells |
[47] |
Knockout mice |
βig-H3 knockout mice are prone to spontaneous tumors |
[58] |
Ovarian carcinoma |
βig-H3 silencing and promoter hypermethylation is a frequent occurrence in ovarian cancer cell lines and ovarian cancer tissues |
[59,60] |
βig-H3 is down-regulated in serous ovarian carcinoma and borderline serous ovarian tumors |
[61] |
βig-H3 induces apotosis in serous ovarian carcinoma cell lines |
[61] |